comScore
Active Stocks
Mon Dec 04 2023 11:43:08
  1. Reliance Industries share price
  2. 2,415 0.9%
  1. State Bank Of India share price
  2. 589.3 3.05%
  1. Tata Steel share price
  2. 130.6 0.5%
  1. HDFC Bank share price
  2. 1,585.25 1.91%
  1. ITC share price
  2. 454.75 1.08%
Business News/ Companies / News/  Dr Reddy's Laboratories launches cancer treatment drug Capecitabine in US
Back Back

Dr Reddy's Laboratories launches cancer treatment drug Capecitabine in US

The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration

Shares of Dr Reddy's Laboratories were trading 0.98% lower at ₹4,650 apiece on BSE.Premium
Shares of Dr Reddy's Laboratories were trading 0.98% lower at 4,650 apiece on BSE.

Drug major Dr Reddy's Laboratories on Wednesday said it has launched cancer treatment drug Capecitabine tablets in the US market.

The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA).

In a regulatory filing, Dr Reddy's laboratories announced launch of Capecitabine tablets in the US.

Also Read  Life lessons from Covidian era startups

Quoting IQVIA Health data, Dr Reddy's said the Xeloda brand and generic had US sales of approximately USD 90 million for the most recent 12 months ending in October 2020.

Dr Reddy's Capecitabine Tablets, USP are available in 150 mg and 500 mg strengths in bottle count sizes of 60 and 120, respectively.

Shares of Dr Reddy's Laboratories were trading 0.98% lower at 4,650 apiece on BSE.

Milestone Alert!
Livemint tops charts as the fastest growing news website in the world 🌏 Click here to know more.

Catch all the Elections News, Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Updated: 17 Feb 2021, 12:22 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App